HR 17299 · 93th Congress · Drug law and legislation

Drug Safety, Consumer Information, and Medical Records Act

Introduced 1974-10-11· Sponsored by Rep. Koch, Edward I. [D-NY-18]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to House Committee on Interstate and Foreign Commerce.(1974-10-11)

Plain Language Summary

[AI summary unavailable — showing source text] Drug Safety, Consumer Information, and Medical Records Act - Title I: National Center for Clinical Pharmacology - Establishes, under the Public Health Service Act and within the Department of Health, Education, and Welfare, the National Center for Clinical Pharmacology to provide support in the nature of grants for the study of clinical pharmacology. Enumerates the nature and general provisions of such grants. Provides for the collection of data regarding drug experiences and adverse drug reactions. Calls for a study to be conducted on the inappropriate prescribing of drugs and on whether controls are needed for such inappropriate prescribing. Requires all organizations receiving assistance under this Act to review the prescribing and administering of all drugs in the course of delivery of health care. Calls for the establishment of procedures to insure the confidentiality of medical records pertaining to the experiences of a specific individual in taking drugs. Provides for Congressional inspection of medical data. Authorizes appropriations through fiscal year 1976 to carry out the purposes and projects of this title. Title II: Promotional Practices - Prohibits, under the Federal …

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

2 Democrats